Research
Metabolic adaptation
BMI and insulin use are jointly associated with one-year follow-up type 2 diabetes-related healthcare expenditures (T2D-HE), ranging from $5842 in overweight patients with no insulin to $17,700 in OCIII insulin users.
Healthcare providers can use BMI and insulin use to identify patients at higher risk for increased healthcare costs.
StrongSupportsmedium confidence
Together, BMI and insulin use were jointly associated with one‐year follow‐up T2D‐HE, which monotonically ranged from $5842 in overweight patients with no insulin to $17 700 OCIII insulin users, P < 0.001.
Why this rating
Based on a large retrospective analysis of patient data.
Source
Body mass index and insulin use as identifiers of high‐cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data
Stephen S. Johnston et al. · Diabetes Obesity and Metabolism · 2019
cohort · n=13026Cited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →